ASPREE-NEURO study protocol: A randomized controlled trial to determine the effect of low-dose aspirin on cerebral microbleeds, white matter hyperintensities, cognition, and stroke in the healthy elderly
Open Access
- 24 September 2016
- journal article
- research article
- Published by SAGE Publications in International Journal of Stroke
- Vol. 12 (1) , 108-113
Abstract
Cerebral microbleeds seen on brain magnetic resonance imaging are markers of small vessel disease, linked to cognitive dysfunction and increased ischemic and hemorrhagic stroke risk. Observational studies suggest that aspirin use may induce cerebral microbleeds, and associated overt intracranial hemorrhage, but this has not been definitively resolved. ASPREE-NEURO will determine the effect of aspirin on cerebral microbleed development over three years in healthy adults aged 70 years and over, participating in the larger ‘ASPirin in Reducing Events in the Elderly (ASPREE)’ primary prevention study of aspirin. Five hundred and fifty-nine participants provide 75% power (two-sided p value of 0.05) to determine an average difference of 0.5 cerebral microbleed per person after three years. A multi-center, randomized placebo-controlled trial of 100 mg daily aspirin in participants who have brain magnetic resonance imaging at study entry, one and three years after randomization and who undergo cognitive testing at the same time points. The primary outcome is the number of new cerebral microbleeds on magnetic resonance imaging after three years. Secondary outcomes are the number of new cerebral microbleeds after one year, change in volume of white matter hyperintensity, cognitive function, and stroke. ASPREE-NEURO will resolve whether aspirin affects the presence and number of cerebral microbleeds, their relationship with cognitive performance, and indicate whether consideration of cerebral microbleeds alters the risk-benefit profile of aspirin in primary prevention for older people. Australian New Zealand Clinical Trials Registry ACTRN12613001313729.Keywords
This publication has 23 references indexed in Scilit:
- Antiplatelet Drug Use and Cerebral Microbleeds: A Meta-analysis of Published StudiesJournal of Stroke and Cerebrovascular Diseases, 2015
- Risk Factors Associated With Incident Cerebral Microbleeds According to Location in Older PeopleJAMA Neurology, 2015
- Cerebral microbleeds: overview and implications in cognitive impairmentAlzheimer's Research & Therapy, 2014
- Cerebral Microbleeds as a Predictor of Macrobleeds: What is the Evidence?International Journal of Stroke, 2014
- Risk Factors, Stroke Prevention Treatments, and Prevalence of Cerebral Microbleeds in the Framingham Heart StudyStroke, 2014
- Cerebral Microbleeds: A Review of Clinical, Genetic, and Neuroimaging AssociationsFrontiers in Neurology, 2014
- Mechanisms of sporadic cerebral small vessel disease: insights from neuroimagingThe Lancet Neurology, 2013
- Cerebral Microbleeds in the ElderlyStroke, 2010
- Prevalence and Risk Factors of Cerebral MicrobleedsStroke, 2010
- Cerebral MicrobleedsArchives of Neurology, 2009